DNQX

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 16:24, 7 July 2015 (Updating {{chembox}} (changes to verified and watched fields) per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DNQX
Names
IUPAC name
6,7-Dinitroquinoxaline-2,3-dione
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
DrugBank
  • InChI=1S/C8H2N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H checkY
    Key: YEUPBRRGMWBCEB-UHFFFAOYSA-N checkY
  • InChI=1/C8H2N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H
    Key: YEUPBRRGMWBCEB-UHFFFAOYAT
  • [O-][N+](=O)C=2\C(=C/C1=N/C(=O)C(=O)/N=C1C=2)[N+]([O-])=O
Properties
C8H2N4O6
Molar mass 250.126 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

DNQX (6,7-dinitroquinoxaline-2,3-dione) is an AMPA and kainate receptor antagonist. It is used in a variety of molecular biology subfields, notably neurophysiology, to assist researchers in determining the properties of various types of ion channels.

See also

References

External links